837
Views
48
CrossRef citations to date
0
Altmetric
Review Article

Inhibition and induction of glutathione S-transferases by flavonoids: possible pharmacological and toxicological consequences

&
Pages 267-286 | Received 29 Jun 2012, Accepted 17 Jul 2012, Published online: 24 Sep 2012

References

  • Abramovitz, M., Homma, H., Ishigaki, S., Tansey, F., Cammer, W., Listowsky, I. (1988). Characterization and localization of glutathione-S-transferases in rat brain and binding of hormones, neurotransmitters, and drugs. J Neurochem 50:50–57.
  • Adler, V, Yin, Z, Fuchs, SY, Benezra, M, Rosario, L, Tew, KD, et al. (1999). Regulation of JNK signaling by GSTp. EMBO J 18:1321–1334.
  • Aherne, S. A., O’Brien, N. M. (2002). Dietary flavonols: chemistry, food content, and metabolism. Nutrition 18:75–81.
  • Ahmad, H., Li, J. X., Polson, M., Mackie, K., Quiroga, W., Patil, B. S. (2006). Citrus limonoids and flavonoids: enhancement of phase II detoxification enzymes and their potential in chemoprevention. In: Patil, B. S., Turner, N. D., Miller, E. G., Brodbelt, J. S. (Eds.), Potential health benefits of citrus (pp. 130–143). Washington, DC: American Chemical Society.
  • Ahmad, R., Srivastava, A. K. (2008). Inhibition of filarial glutathione-S-transferase by various classes of compounds and their evaluation as novel antifilarial agents. Helminthologia 45:114–120.
  • Ansell, P. J., Espinosa-Nicholas, C., Curran, E. M., Judy, B. M., Philips, B. J., Hannink, M., et al. (2004). In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens. Endocrinology 145:311–317.
  • Apati, P., Houghton, P. J., Kite, G., Steventon, G. B., Kery, A. (2006). In-vitro effect of flavonoids from Solidago canadensis extract on glutathione S-transferase. J Pharm Pharmacol 58:251–256.
  • Appelt, L. C., Reicks, M. M. (1999). Soy induces phase II enzymes but does not inhibit dimethylbenz(a)antracene-induced carcinogenesis in female rats. J Nutr 129:1820–1826.
  • Armstrong, R. N. (1997). Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem Res Toxicol 10:2–18.
  • Artali, R., Beretta, G., Morazzoni, P., Nomnardelli, E., Meneghetti, F. (2009). Green tea catechins in chemoprevention of cancer. A molecular docking inestigation into their ineraction with glutathione S-transferase GSTP1-1. J Enzyme Inhib Med Chem 24:287–295.
  • Awasthi, S. K., Mishra, N., Dixit, S. K., Singh, A., Yadav, M., Yadav, S. S., et al. (2009). Antifilarial activity of 1,3-diarylpropen-1-one: effect on glutathione-S-transferase, a phase II detoxification enzyme. Am J Trop Med Hyg 80:764–768.
  • Awasthi, Y. C., Yang, Y., Tiwari, N. K., Patrick, B., Sharma, A., Li, J., et al. (2004). Regulation of 4-hydroxynonenal-mediated signaling by glutathione S-transferases. Free Radic Biol Med 37:607–619.
  • Atkinson, H. J., Babbitt, P. C. (2009). Glutathione transferases are structural and functional outliers in the thioredoxin fold. Biochemistry 48:11108–11116.
  • Axarli, I. A., Rigden, D. J., Labrou, N. E. (2004). Characterization of the ligandin site of maize glutathione S-transferase I. Biochem J 382:885–893.
  • Barnouin, K., Leier, I., Jedlitschky, G., Pourtier-Manzanedo, A., König, J., Lehmann, W. D., et al. (1998). Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione. Br J Cancer 77:201–209.
  • Bartholomaeus, A. R., Bolton, R., Ahokas, J. T. (1994). Inhibition of rat liver cytosolic glutathione S-transferase by silybin. Xenobiotica 24:17–24.
  • Bayram, B., Ozcelik, B., Grimm, S., Roeder, T., Schrader, C., Ernst, I. M. A., et al. (2012). A diet rich in olive phenolics reduces oxidative stress in the heart of SAMP8 mice by induction of Nrf2-dependent gene expression. Rejuv Res 15:71–81.
  • Beecher, G. R. (2003). Overview of dietary flavonoids: nomenclature, occurrence and intake. J Nutr 133:3248S–3254S.
  • Beuckmann, C. T., Fujimori, K., Urade, Y., Hayaishi, O. (2000). Identification of mu-class glutathione transferases M2-2 and M3-3 as cytosolic prostaglandin E synthases in the human brain. Neurochem Res 25:733–738.
  • Bhatia, K., Rahman, S., Ali, M., Raisuddin, S. (2006). In vitro antioxidant activity of Juglans regia bark extract and its protective effect on cyclophosphamide-induced urotoxicity in mice. Redox Rep 6:273–279.
  • Boots, A. W., Haenen, G. R., Bast, A. (2008). Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585:325–337.
  • Boušová, I., Hájek, J., Dršata, J., Skálová, L. (2012). Naturally occurring flavonoids as inhibitors of purified cytosolic glutathione S-transferase. Xenobiotica 2012 Mar 30. [Epub ahead of print]
  • Cabrera, M, Lavaggi, ML, Croce, F, Celano, L, Thomson, L, Pintos, C, et al. (2010). Identification of chalcones as in vivo liver monofunctional phase II inducers. Bioorg Med Chem 18:5391–5399.
  • Campling, B. G., Baer, K., Baker, H. M., Lam, Y. M., Cole, S. P. (1993). Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines? Br J Cancer 68:327–335.
  • Castro-Caldas, M., Milagre, I., Rodrigues, E., Gama, M. J. (2009). Glutathione S-transferase pi regulates UV-induced JNK signaling in SH-SY5Y neuroblastoma cells. Neurosci Lett 451:241–245.
  • Cermak, R. (2008). Effect of dietary flavonoids on pathways involved in drug metabolism. Expert Opin Drug Metab Toxicol 4:17–35.
  • Chang, H. C., Chen, H. W., Tung, H. S., Liu, K. L., Tsai, C. W., Li, C. K. (2010). Butein up-regulates the expression of the pi class of glutathione S-transferase in rat primary hepatocytes through the ERK/AP-1 pathway. J Agric Food Chem 58:8994–9000.
  • Chaudhary, P., Sharma, R., Sharma, A., Vatsyayan, R., Yadav, S., Singhal, S. S., et al. (2010). Mechanisms of 4-hydroxy-2-nonenal induced pro- and anti-apoptotic signaling. Biochemistry 49:6263–6275.
  • Chen, W. Y., Hsieh, Y. A., Tsai, C. I., Kang, Y. F., Chang, F. R., Wu, Y. C., et al. (2011). Protoapigenone, a natural derivative of apigenin, induces mitogen-activated protein kinase-dependent apoptosis in human breast cancer cells associated with induction of oxidative stress and inhibition of glutathione S-transferase π. Invest New Drugs 29:1347–1359.
  • Chen, C., Yu, R., Owuor, E. D., Kong, A. N. T. (2000). Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res 23:605–612.
  • Cheng, J. Z., Singhal, S. S., Sharma, A., Saini, M., Yang, Y., Awasthi, S., et al. (2001). Transfection of mGSTA4 in HL-60 cells protects against 4-hydroxynonenal-induced apoptosis by inhibiting JNK-mediated signaling. Arch Biochem Biophys 392:197–207.
  • Chow, H. H., Hakim, I. A., Vining, D. R., Crowell, J. A., Tome, M. E., Ranger-Moore, J., et al. (2007). Modulation of human glutathione S-transferases by Polyphenon E intervention. Cancer Epidemiol Biomarkers Prev 16:1662–1666.
  • Cipak, L., Berczeliova, E., Paulikova, H. (2003). Effects of flavonoids on glutathione a glutathione-related enzymes in cisplatin-treated L1210 leukemia cells. Neoplasma 50:443–446.
  • Cirico, T. L., Omaye, S. T. (2006). Additive or synergetic effects of phenolic compounds on human low density lipoprotein oxidation. Food Chem Toxicol 44:510–516.
  • Coles, B. F., Kadlubar, F. F. (2005). Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. Methods Enzymol 401: 9–42.
  • Conklin, D. J., Haberzettl, P., Lesgards, J. F., Srivastava, S., Bhatnagar, A. (2009). Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity. J Pharm Pharmacol Exp Ther 331:456–469.
  • Cushnie, T. P., Lamb, A. J. (2005). Antimicrobial activity of flavonoids. Int J Antimicrob Agents 26:343–356.
  • Das, M., Singh, S. V., Mukhtar, H., Awasthi, Y. C. (1986). Differential inhibition of rat and human glutathione S-transferase isoenzymes by plant phenols. Biochem Biophys Res Commun 141:1170–1176.
  • Das, S., Roy, P., Auddy, R. G., Mukherjee, A. (2011). Silymarin nanoparticle prevents paracetamol-induced hepatotoxicity. Int J Nanomed 6:1291–1301.
  • de Lange, D. W., Verhoef, S., Gorter, G., Kraaijenhagen, R. J., van de Wiel, A., Akkerman, J. W. (2007). Polyphenolic grape extract inhibits platelet activation through PECAM-1: an explanation for the French paradox. Alcohol Clin Exp Res 31:1308–1314.
  • Den Boer, M. L., Pieters, R., Kazemier, K. M., Henze, G., Kaspers, G. J. L., Kearns, P. R., et al. (1999). Different expression of glutatione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukemia. Br J Haematol 104:321–327.
  • Dewick, P. M. (2002). Medicinal natural products, a biosynthetic approach. Chichester, UK: John Wiley & Sons.
  • Dorion, S., Lambert, H., Landry, J. (2002). Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase Mu from Ask1. J Biol Chem 277:30792–30797.
  • Dourado, D. F., Fernandes, P. A., Ramos, M. J. (2008). Mammalian cytosolic glutathione transferases. Curr Protein Pept Sci 9:325–337.
  • Durgo, K., Vukovic, L., Rusak, G., Osmak, M., Colic, J. F. (2009). Cytotoxic and apoptotic effect of structurally similar flavonoids on parental and drug-resistant cells of human cervical carcinoma. Food Technol Biotechnol 47:356–363.
  • Ebert, M. N., Klinder, A., Peters, W. H., Schäferhenrich, A., Sendt, W., Scheele, J., et al. (2003). Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis 24:1637–1644.
  • Egert, S., Rimbach, G. (2011). Which sources of flavonoids: complex diets or dietary supplements? Adv Nutr 2:8–14.
  • Ekhart, C., Doodeman, V. D., Rodenhuis, S., Smits, P., Beijnen, J. H., Huitema, A. D. R. (2009). Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6, and CYP3A) affect the pharmacokinetics of thiotepa and tepa. Br J Clin Pharmacol 67:50–60.
  • Fernández-Cañón, J. M., Peñalva, M. A. (1998). Characterization of a fungal maleylacetoacetate isomerase gene and identification of its human homologue. J Biol Chem 273:329–337.
  • Ferreira, D., Slade, D., Marais, J. P. J. (2006). Flavans and proanthocyanidins. In: Andersen, O. M., Markham, K. R. (Eds.), Flavonoids: chemistry, biochemistry, and applications (pp. 553–617). Boca Raton, Florida, USA: CRC.
  • Frova, C. (2006). Glutathione transferases in the genomics era: new insights and perspectives. Biomol Eng 23:149–169.
  • Froyen, E. B., Reeves, J. L. R., Mitchel, A. E., Steinberg, F. M. (2009). Regulation of phase II enzymes by genistein and daidzein in male and female Swiss Webster mice. J Med Food 12:1227–1237.
  • Gilbert, L., Elwood, L. J., Merino, M., Masood, S., Barnes, R., Steinberg, S. M., et al. (1993). A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol 11:49–58.
  • Goh, K., Chen, Y., Zheng, L., Ong, L., Jin, Y., Chow, P., et al. (2008). 2,2′-Dihydroxychalcone, a glutathione transferase inhibitor, sensitises human colon adenocarcinoma cells to chlorambucil and melphalan, but not to actinomycin D. Mol Med Report 4:575–579.
  • Gong, Y., Han, C., Chen, J. (2000). Effect of tea polyphenols and tea pigments on the inhibition of precancerous liver lesions in rats. Nutr Cancer 38:81–86.
  • Halliwell, B. (2007). Dietary polyphenols: good, bad, or indifferent for your health? Cardiovasc Res 73:341–347.
  • Halliwell, B. (2008). Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch Biochem Biophys 476:107–112.
  • Hanušová, V., Boušová, I., Skálová, L. (2011). Possibilities to increase the effectiveness of doxorubicin in cancer cells killing. Drug Metab Rev 43:540–557.
  • Hayes, J. D., Flanagan, J. U., Jowsey, I. R. (2005). Glatathione transferases. Annu Rev Pharmacol Toxicol 45:51–88.
  • Hayes, J. D., McMahon, M. (2001). Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett 174:103–113.
  • Hayes, P. C., Bouchier, I. A. D., Beckett, G. J. (1991). Glutathione S-transferase in humans in health and disease. Gut 32:813–818.
  • Hayeshi, R., Mutingwende, I., Mavengere, W., Masiyanise, V., Mukanganyama, S. (2007). The inhibition of human glutathione S-transferases activity by plant polyphenolic compounds ellagic acid and curcumin. Food Chem Toxicol 45:286–295.
  • Higgins, L. G., Hayes, D. (2011). Mechanisms of induction of cytosolic and microsomal glutathione transferase (GST) genes by xenobiotics and pro-inflamatory agents. Drug Metab Rev 43:92–137.
  • Horton, J. K., Roy, G., Piper, J. T., Van Houten, B., Awasthi, Y. C., Mitra, S., et al. (1999). Characterization of a chlorambucil-resistant human ovarian carcinoma cell line overexpressing glutathione S-transferase mu. Biochem Pharmacol 58:693–702.
  • Hubatsch, I., Ridderström, M., Mannervik, B. (1998). Human glutathione transferase A 4-4: an alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation. Biochem J 330:175–179.
  • Hubbard, G. P., Wolffram, S., Lovegrove, J. A., Gibbins, J. M. (2004). Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost 2:2138–2145.
  • Hurst, R., Bao, Y., Jemth, P., Mannervik, B., Williamson, G. (1998). Phospholipid hydroperoxide glutathione transferase activity of human glutathione transferases. Biochem J 332:97–100.
  • Iio, M., Kawaguchi, H., Sakota, Y., Otonari, J., Nitahara, H. (1993). Effects of polyphenols, including flavonoids, on glutathione S-transferase and glutathione reductase. Biosci Biotechnol Biochem 57:1678–1680.
  • Jakobsson, P. J., Morgenstern, R., Mancini, J., Ford-Hutchinson, A., Persson, B. (1999a). Common structural features of MAPEG—a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism. Protein Sci 8:689–692.
  • Jakobsson, P. J., Thorén, S., Morgenstern, R., Samuelsson, B. (1999b). Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A 96:7220–7225.
  • Johansson, A. S., Mannervik, B. (2001). Human glutathione transferase A3-3, a highly efficient catalyst of double-bond isomerization in the biosynthetic pathway of steroid hormones. J Biol Chem 276:33061–33065.
  • Jodynis-Liebert, J., Matlawska, I., Bylka, W., Murias, M. (2005). Protective effect of Aquilegia vulgaris on APAP-induced oxidative stress in rats. J Ethnopharmacol 97:351–358.
  • Jovanovic, S. V., Steenken, S., Tosic, M., Marjanovic, B., Simic, M. G. (1994). Flavonoids as antioxidants. J Am Chem Soc 116:4846–4851.
  • Jowsey, I. R., Thomson, A. M., Flanagan, J. U., Murdock, P. R., Moore, G. B., Meyer, D. J., et al. (2001). Mammalian class sigma glutathione S-transferases: catalytic properties and tissue-specific expression of human and rat GSH-dependent prostaglandin D2 synthases. Biochem J 359:507–516.
  • Kang, K. W., Park, E. Y., Kim, S. G. (2003). Activation of CCAAT/enhancer-binding protein beta by 20-amino-30-methoxyflavone (PD98059) leads to the induction of glutathione S- transferase A2. Carcinogenesis 24:475–482.
  • Kessler, M., Ubeaud, G., Jung, L. (2003). Anti- and pro-oxidant activity of rutin and quercetin derivatives. J Pharm Pharmacol 55:131–142.
  • Ketley, J. N., Habig, W. H., Jakoby, W. B. (1975). Binding of nonsubstrate ligands to the glutathione S-transferases. J Biol Chem 250:8670–8673.
  • Khatiwada, J., Verghese, M., Walker, L. T., Shackelford, L., Chawan, C. B., Sunkura, R. (2006). Combination of green tea, phytic acid, and inositol reduced the incidence of azoxymethane-induced colon tumors in Fisher 344 male rats. LWT-Food Sci Technol 39:1080–1086.
  • Kim, Y. W., Kang, H. E., Lee, M. G., Hwang, S. J., Kim, S. C., Lee, C. H., et al. (2009). Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase II enzymes. Am J Physiol 296:G372–G381.
  • Kohno, H., Tanaka, T., Kawabata, K., Hirose, Y., Sugie S., Tsuda H., et al. (2002). Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats. Int J Cancer 101:461–468.
  • Kolobe, D., Sayed, Y., Dirr, H. W. (2004). Characterization of bromosulphophthalein binding to human glutathione S-transferase A1-1: thermodynamics and inhibition kinetics. Biochem J 382:703–709.
  • Kong, A. N. T, Yu, R., Hebbar, V., Chen, C., Owuor, E., Hu, R., et al. (2001). Signal transduction events elicited by cancer prevention compounds. Mutat Res 480:231–241.
  • Kupeli, E., Orhan, D., Yeslida, E. (2006). Effect of Cistus laurifolius L leaf extracts and flavonoids on acetaminophen-induced hepatotoxiciy in mice. J Ethnopharmacol 103:455–460.
  • Laborde, E. (2010). Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death. Cell Death Differ 17:1373–1380.
  • Li, N., Muthusamy, S., Liang, R. Q., Sarojini, H., Wang, E. (2011). Increased expression of miR-34a and miR-93 in rat liver during aging and their impact on the expression of mGST1 and Sirt1. Mechan Ageing Dev 132:75–85
  • Lucena, M. I., Andrade, R. J., Martinez, C., Ulzurrun, E., Castiell, A., Planas, R., et al. (2008). Glutathione S-transferase M1 and T1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury. Hepatology 48:588–596.
  • Lyon, R. P., Atkins, W. M. (2002). Kinetic characterization of native and cysteine 112-modified glutathione S-transferase A1-1: reassessment of nonsubstrate ligand binding. Biochemistry 41:10920–10927.
  • Maglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D., Moore, J. T., Kliewe, S. A. (2002). Nucler pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol 62:638–646
  • Mahajan, S., Atkins, W. M. (2005). The chemistry and biology of inhibitors and pro-drugs targeted to glutathione S-transferases. Cell Mol Life Sci 62:1221–1233.
  • Maliakal, P. P., Coville, P. F., Wanwimolruk, S. (2001). Tea consumption modulates hepatic drug metabolizing enzymes in Wistar rats. J Pharm Pharmacol 53:569–577.
  • Mannervik, B., Board, P. G., Hayes, J. D., Listowsky, I., Pearson, W. R. (2005). Nomenclature for mammalian soluble glutathione transferases. Methods Enzymol 401:1–8.
  • Mandlekar, S., Hong, J. L., Kong, A. N. T. (2006). Modulation of metabolic enzymes by dietary phytochemicals: a review of mechanisms underlying beneficial versus unfavorable effects. Curr Drug Metab 7:661–675.
  • Mathew, N., Kalyanasundaram, M., Balaraman, K. (2006). Glutathione S-transferase (GST) inhibitors. Expert Opin Ther Pat 16:431–444.
  • McLellan, L. I., Wolf, C. R. (1999). Glutathione and glutathione-dependent enzymes in cancer drug resistance. Drug Resist Updat 2:153–164.
  • McMahon, M., Itoh, K., Yamamoto, M., Chanas, S. A., Henderson, C. J., McLellan, L. I., et al. (2001). The Cap n Collar basic leucine zipper transcription factor Nrf2 (NF-E2p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 61:3299–3307.
  • Merlos, M., Sanchez, R. M., Camarasa, J., Adzet, T. (1991). Flavonoids as inhibitors of rat liver cytosolic glutathione S-transferase. Experientia 47:616–619.
  • Mesía-Vela, S., Kauffman, F. C. (2003). Inhibition of rat liver sulfotransferases SULT1A1 and SULT2A1 and glucuronosyltransferase by dietary flavonoids. Xenobiotica 33:1211–1220.
  • Metodiewa, D., Jaiswal, A. K., Cenas, N., Dickancaite, E., Segura-Aguilar, J. (1999). Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med 26:107–116.
  • Middleton, E., Jr., Kandaswami, C., Theoharides, T. C. (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52:673–751.
  • Mira, L., Fernandez, M. T., Santos, M., Rocha, R., Florencio, M. H., Jennings, K. R. (2002). Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res 36:1199–1208.
  • Mishra, A., Chandra, R., Mehrotra, P. K., Agrawal, D. (2011). Glutathione S-transferase M1 and T1 polymorphism and respose to neoadjuvant chemotherapy (CAF) in breast cancer patients. Surg Today 4:471–476.
  • Mitchell, A. E., Burns, S. A., Rudolf, J. L. (2007). Isoenzyme-and gender- specific induction of glutathione S-transferases by flavonoids. Arch Toxicol 81:777–784.
  • Miyanishi, K., Takayama, T., Ohi, M., Hayashi, T., Nobuoka, A., Nakajima, T., et al. (2001). Glutathione S-transferase-pi overexpression is closely associated with K-ras mutation during human colon carcinogenesis. Gastroenterology 121:865–874.
  • Moon, Y. J., Wang, X., Morris, M. E. (2006). Dietary flavonoids: effect on xenobiotic and carcinogen metabolism. Toxicol In Vitro 20:187–210.
  • Morales, G. A., Laborde, E. (2007). Small-molecule inhibitors of glutathione S-transferase P1-1 as anticancer therapeutic agents. Annu Rep Med Chem 42:321–335.
  • Morel, F., Rauch, C., Petit, E., Piton, A., Theret, N., Coles, B., et al. (2004). Gene and protein characterization of the human glutathione S-transferase kappa and evidence for a peroxisomal localization. J Biol Chem 279:16246–16253.
  • Nagaprashantha, L. D., Vatsyayan, R., Singhal, J., Lelsani, P., Prokai, L., Awasthi, S., et al. (2011). 2′-hydroxyflavanone inhibits proliferation, tumor vascularization, and promotes normal differentiation in VHL-mutant renal cell carcinoma. Carcinogenesis 32:568–575.
  • Nakatsuma, A., Fukami, T., Suzuki, T., Furushi, T., Tomono, K., Hidaka, S. (2010). Effects of kaempferol on the mechanisms of drug resistence in the human glioblastoma cell line T98G. Pharmazie 65:379–383.
  • Nijhoff, W. A., Bosboom, M. A., Smidt, M. H., Peters, W. H. M. (1995). Enhancement of rat hepatic and gastrointestinal glutathione S-transferase by α-angelicalactone and flavones. Carcinogenesis 16:607–612.
  • Nishimura, M., Naito, S. (2006). Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes. Drug Metab Pharmacokinet 21:357–374.
  • Noguchi, K., Katayama, K., Mitsuhashi, J., Sugimoto, Y. (2009). Functions of breast cancer resistence protein (BCRP/ABCG2) in chemotherapy. Adv Drug Delivery Rev 61:26–33.
  • Oakley, A. J., Lo Bello, M., Nuccetelli, M., Mazzetti, A. P., Parker, M. W. (1999). The ligandin (non-substrate) binding site of human Pi class glutathione transferase is located in the electrophile binding site (H-site). J Mol Biol 291:913–926.
  • Oakley, A. (2011). Glutathione transferases: a structural perspective. Drug Metab Rev 43:138–151.
  • Oliveira, A. L., Rodrigues, F., Santos, R., Rocha, M., Longui, C., Melo, M. B. (2010). GSTT1, GSTM1, and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer. Gen Mol Res 9:1045–1053.
  • Owuor, E. D., Kong, A. T. (2002). Antioxidants and oxidants regulated signal transduction pathways. Biochem Pharmacol 64:765–770.
  • Oz, H. S., McClain, C. J., Nagasawa, H. T., Ray, M. B., de Williers, W., Chen, T. S. (2004). Diverse antioxidants protect against acetaminophen hepatotoxicity. J Biochem Mol Toxicol 8:361–368.
  • Parkinson, A. (2001). Biotransformation of xenobiotics. In: Klaassen, C. D. (Ed.) Casarett & Doull’s toxicology: the basic science of poisons (pp. 133–224). New York: McGraw-Hill.
  • Parvez, S., Tabassum, H., Rehman, H., Basu, D., Athar, M. (2006). Catechin prevents tamoxifen-induced oxidative stress and biochemical perturbations in mice. Toxicology 225:109–118.
  • Peklak-Scott, C., Townsend, A. J., Morrow, C. S. (2005). Dynamics of glutathione conjugation and conjugate efflux in detoxification of the carcinogen, 4-nitroquinoline 1-oxide: contributions of glutathione, glutathione S-transferase, and MRP1. Biochemistry 44:4426–4433.
  • Pemble, S. E., Wardle, A. F., Taylor, J. B. (1996). Glutathione S-transferase class kappa: characterization by the cloning of rat mitochondrial GST and identification of a human homologue. Biochem J 319:749–754.
  • Peters, W. H., Wormskamp, N. G., Thies, E. (1990). Expression of glutathione S-transferases in normal gastric mucosa and in gastric tumors. Carcinogenesis 11:1593–1596.
  • Pietta, P. G. (2000). Flavonoids as antioxidants. J Nat Prod 63:1035–1042.
  • Polekhina, G., Board, P. G., Blackburn, A. C., Parker, M. W. (2001). Crystal structure of maleylacetoacetate isomerase/glutathione transferase zeta reveals the molecular basis for its remarkable catalytic promiscuity. Biochemistry 40:1567–1576.
  • Poonkuzhali, B., Chandy, M., Srivastava, A., Dennison, D., Krishnamoothry, R. (2001). Glutathione S-transferase activity influences busulfan pharmacokinetics in patients undergoing bone marrow transplantation. Drug Metab Dispos 29:264–267.
  • Prade, L., Huber, R., Manoharan, T. H., Fahl, W. E., Reuter, W. (1997). Structures of class pi glutathione S-transferase from human placenta in complex with substrate, transition-state analogue and inhibitor. Structure 5:1287–1295.
  • Procházková, D., Boušová, I., Wilhelmová, N. (2011). Antioxidant and prooxidant properties of flavonoids. Fitoterapia 82:513–523.
  • Raijmakers, M. T. M., Steegers, E. A. P., Peters, W. H. M. (2001). Glutathione S-transferases and thiol concentrations in embryonic and early fetal tissues. Hum Reprod 16:2445–2450.
  • Ramos-Gomez, M., Kwak, M. K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., et al. (2001). Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci U S A 98:3410–3415.
  • Rathaur, S., Yadav, M., Singh, N., Singh, A. (2011). Effect of diethylcarbamazine, butylated hydroxy anisole, and methyl substituted chalcone on filarial parasite Setaria cervi: proteomic and biochemical approaches. J Proteomics 74:1595–1606.
  • Rea, V., Dragovic, S., Boerma, J. S., de Kanter, F., Vermeulen, N. P. E., Commandeur, J. N. M. (2011). Application for structural characterization of clozapine GSH conjugates. Drug Metab Dispos 39:2411–2420.
  • Renugadevi, J., Prabu, S. M. (2010). Cadmium-induced hepatotoxicity in rats and the protective effect of naringenin. Exp Toxicol Pathol 62:171–181.
  • Rice-Evans, C. A., Miller, N. J., Paganga, G. (1996). Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20:933–956.
  • Rodeiro, I., Donato, M. T., Lahoz, A., Garrido, G., Delgado, R., Gómez-Lechón, M. J. (2008). Interactions of polyphenols with the P450 system: possible implications on human therapeutics. Mini Rev Med Chem 8:97–106.
  • Romero, L., Andrews, K., Ng, L., O’Rourke, K., Maslen, A., Kirby, G. (2006). Human GSTA1-1 reduces c-Jun N-terminal kinase signalling and apoptosis in Caco-2 cells. Biochem J 400:135–141.
  • Rudolf, J. L., Bauerly, K. A., Tchaparian, E., Rucker, R. B., Mitchell, A. E. (2008). The influence of diet composition on phase I and II biotransformation enzyme induction. Arch Toxicol 82:893–901.
  • Ruzza, P., Rosato, A., Rossi, C. R., Floreani, M., Quintieri, L. (2009). Glutathione transferases as targets for cancer therapy. Anticancer Agents Med Chem 9:763–777.
  • Ryoo, K., Huh, S. H., Lee, Y. H., Yoon, K. W., Cho, S. G., Choi, E. J. (2004). Negative regulation of MEKK1-induced signaling by glutathione S-transferase mu. J Biol Chem 279:43589–3594.
  • Sau, A., Tregno, F. P., Valentino, F., Federici, G., Caccuri, A. C. (2010). Glutathione transferases and development of new principles to overcome drug resistance. Arch Biochem Biophys 500:116–122.
  • Sau, A., Filomeni, G., Pezzola, S., D’Aguanno, S., Tregno, F. P., Urbani, A., et al. (2012). Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines. Mol BioSyst 8:994–1006.
  • Sahu, S. C., Gray, G. C. (1996). Pro-oxidant activity of flavonoids: effects on glutathione and glutathione S-transferase in isolated rat liver nuclei. Cancer Lett 104:193–196.
  • Seeley, S. K., Poposki, J. A., Maksimchuk, J., Tebbe, J., Gaudreau, J., Mannervik, B., et al. (2006). Metabolism of oxidized linoleic acid by glutathione transferases: peroxidase activity toward 13-hydroperoxyoctadecadienoic acid. Biochim Biophys Acta 1760:1064–1070.
  • Sharda, S. V., Gulati, S., Tripathi, G., Jafar, T., Sharma, R., Agrawal, S. (2008). Do glutathione S-transferases polymorphisms influence response to intravenous cyclophosphamide therapy in idiopathic nephritic syndrome? Ped Nephrol 11:2001–2006.
  • Sharma, N., Trikha, P., Athar, M., Raisuddin, S. (1999). Protective effect of Cassia occidentalis extract on chemical-induced chromosomal aberrations in mice. Drug Chem Toxicol 22:643–653.
  • Simůnek, T., Stérba, M., Popelová, O., Adamcová, A., Hrdina, R., Gersl, V. (2009). Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Reports, 61, 154–71.
  • Srinivasan, L., Mathew, N., Muthuswamy, K. (2009). In vitro antifilarial activity of glutathione S-transferase inhibitors. Parasitol Res 105:1179–1182.
  • Srivastava, A., Poonkuzhali, B., Shaji, R. V., Mathews, V., Chandy, M., Krishnamoorthy, R. (2004). Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venooclusive disease in bone marrow transplantation. Blood 104:1574–1577.
  • Staedler, D., Idrizi, E., Kenzaoui, B. H., Juillerat-Jeanneret, L. (2011). Drug combination with quercetin: doxorubicin plus quercetin in human breast cancer cells. Cancer Chemotherap Pharmacol 68:1161–1172.
  • Subramanian, R., Fang, X., Prueksaritanont, T. (2002). Structural characterization of in vivo rat glutathione adducts and a hydroxylated metabolite of simvastatin hydroxy acid. Drug Metab Dispos 30:225–230.
  • Suganuma, M., Saha, A., Fujiki, H. (2011). New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci 102:317–323.
  • Svehlikova, V., Wang, S., Jakubikova, J., Williamson, G., Mithen, R., Bao, Y. (2004). Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cells. Carcinogenesis 25:1629–1637.
  • Tanaka, T., Kawabata, K., Kakumoto, M., Makita, H., Ushida, J., Honjo, S., et al. (1999). Modifying effects of flavonoid morin on azoxymethane-induced large bowel tumorigenesis in rats. Carcinogenesis 20:1477–1484.
  • Testa, B., Krämer, S. D. (2010). The biochemistry of drug metabolism: conjugations, consequences of metabolism, influencing factors. Zürich, Switzerland: Willey-VCH.
  • Tew, K. D., Dutta, S., Shultz, M. (1997). Inhibitors of glutatione S-tranferases as therapeutic agents. Adv Drug Deliv Rev 26:91–104.
  • Tew, K. D., Manevich, Y., Grek, C., Xiong, Y., Uys, J., Townsend, D. M. (2011). The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer. Free Radic Biol Med 51:299–313.
  • Tew, K. D., Monks, A., Barone, L., Rosser, D., Akerman, G., Montali, J. A., et al. (1996). Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program. Mol Pharmacol 50:149–159.
  • Tiku, A. B., Abraham, S. K., Kale, R. K. (2008). Protective effect of the cruciferous vegetable mustard leaf against in vivo chromosomal damage and oxidative stress induced by gamma radiation and genotoxic chemicals. Environ Mol Mutagen 49:335–342.
  • Tomas-Barberan, F. A., Clifford, M. N. (2000). Flavanones, chalcones and dihydrochalcones—nature, occurrence, and dietary burden. J Sci Food Agric 80:1073–1080.
  • Torres-Rivera, A., Landa, A. (2008). Glutathione transferases from parasites: a biochemical view. Acta Trop 105:99–112.
  • Townsend, D. M., Findlay, V. L., Tew, K. D. (2005). Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets. Methods Enzymol 401:287–307.
  • Townsend, D. M., Tew, K. D. (2003). The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22:7369–7375.
  • Townsend, D. M., Manevich, Y., He, L., Hutchens, S., Pazoles, C. J., Tew, K. D. (2009). Novel role for glutathione S-transferase pi. Regulator of protein S-glutathionylation following oxidative and nitrosative stress. J Biol Chem 284:436–445.
  • Uetrecht, J. P., Trager, W. (2007). Drug metabolism: chemical and enzymatic aspects. New York: Informa Healthcare.
  • Uzun, F. G., Demir, F., Kalendar, S., Bas, H., Kalendar, Y. (2010). Protective effect of catechins and quercetin on chlorpyrifos-induced lung toxicity in male rats. Food Chem Toxicol 48:1714–1720.
  • van Bladeren, P. J. (2000). Glutathione conjugation as a bioactivation reaction. Chem Biol Interact 129:61–76.
  • van Bladeren, P. J., van Ommen, B. (1991). The inhibition of glutathione S-transferases: mechanisms, toxic consequences, and therapeutic benefits. Pharmacol Ther 51:35–46.
  • van Lieshout, E. M. M., Bedaf, M. M. G., Ekkel, M. P. C., Nijhoff, W. A., Peters, W. H. M. (1998). Effects of dietary anticarcinogens on rat gastrointestinal glutathione S-transferase theta 1-1 levels. Carcinogenesis 19:2055–2057.
  • van Zanden, J. J., Ben Hamman, O., van Lersel, M. L. P. S., Boeren, S., Cnubben, N. H. P., Lo Bello, M., et al. (2003). Inhibition of human glutathione S-transferase P1-1 by the flavonoid quercetin. Chem Biol Interact 145:139–148.
  • van Zanden, J. J., Geraets, L., Wortelboer, H. M., van Bladeren, P. J., Rietjens, I. M., Cnubben, N. H. (2004). Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. Biochem Pharmacol 67:1607–1617.
  • Veitch, N. C., Grayer, R. J. (2006). Chalcones, dihydrochalcones, and aurones. In: Andersen, O. M., Markham, K. R. (Eds.), Flavonoids: chemistry, biochemistry, and applications (pp. 1003–1100). Boca Raton, Florida, USA: CRC.
  • Waldon, D. J., Teffera, Y., Colleti, A., Liu, J., Zucher, D., Copeland, K., et al. (2010). Identification of quinine imine containing glutathione conjugates of diclofenac in rat bile. Chem Res Toxicol 23:1947–1953.
  • Wang, J., Zhang, W., Zhu, D., Zhu, X., Pang, X., Qu, W. (2011). Hypolipidaemic and hypoglycaemic effects of total flavonoids from seed residues of Hippophae rhamnoides L. in mice fed a high-fat diet. J Sci Food Agric 91:1446–1451.
  • Wang, T., Arifoglu, P., Ronai, Z., Tew, K. D. (2001). Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J Biol Chem 276:20999–21003.
  • Whitbread, A. K., Tetlow, N., Eyre, H. J., Sutherland, G. R., Board, P. G. (2003). Characterization of the human omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics 13:131–144.
  • Wiegand, H., Boesch-Saadatmandi, C., Regos, I., Treuter, D., Wolffram, S., Rimbach, G. (2009a). Effects of quercetin and catechin on hepatic glutathione-S-transferase (GST), NAD(P)H quinone oxidoreductase 1 (NQO1), and antioxidant enzyme activity levels in rats. Nutr Cancer 61:717–722.
  • Wiegand, H., Wagner, A. E., Boesch-Saadatmandi, C., Kruse, H. P., Kulling, S., Rimbach, G. (2009b). Effect of dietary genistein on phase II and antioxidant enzymes in rat liver. Cancer Genomics Proteomics 6:85–92.
  • Williams, C. A., Grayer, R. J. (2004). Anthocyanins and other flavonoids. Nat Prod Rep 21:539–573.
  • Winkel-Shirley, B. (2001). Flavonoid biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology. Plant Physiol 126:485–493.
  • Wu, G., Vashishtha, S. C., Erve, J. C. L. (2010). Characterization of glutathione conjugates of duloxetine by mass spectrometry and evaluation of in silico approaches. Chem Res Toxicol 23:1393–1404.
  • Wu, Y., Fan, Y., Xue, B., Luo, L., Shen, J., Zhang, S., et al. (2006). Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 25:5787–5800.
  • Xu, C., Li, C. Y., Kong, A. N. T. (2005). Induction of phase I, II, and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28:249–268.
  • Yin, Z. L., Dahlstrom, J. E., Le Couteur, D. G., Board, P. G. (2001). Immunohistochemistry of omega class glutathione S-transferase in human tissues. J Histochem Cytochem 49:983–987.
  • Zhang, K., Das, N. P. (1994). Inhibitory effects of plant polyphenols on rat liver glutathione S-transferases. Biochem Pharmacol 47:2063–2068.
  • Zhang, Y., Gordon, G. B. (2004). A strategy for cancer prevention: stimulation of the Nrf2-ARE signaling pathway. Mol Cancer Ther 3:885–893.
  • Zhang, K., Wong, K. P., Chow, P. (2003). Conjugation of chlorambucil with GSH by GST purified from human colon adenocarcinoma cells and its inhibition by plant polyphenols. Life Sci 72:2629–2640.
  • Zhao, T. J., Singhal, S. S., Piper, J. T., Cheng, J. Z., Pandya, U., Clark-Wronski, J., et al. (1999). The role of human glutathione S-transferases hGSTA1-1 and hGSTA2-2 in protection against oxidative stress. Arch Biochem Biophys 367:216–224.
  • Zielińska, E., Bodalski, J. (2001). Growth retardation and osteomalacia as a result of ifosfamide nephrotoxicity in a 3-year-old boy whose genotype revers the genes enconding GSTM1 and GSTT1. Cytobios 106:193–200.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.